Towards a revised nomenclature for P1 and P2 receptors.

The classification of receptors for adenosine, ATP and ADP (collectively called purinoceptors) has seen a number of developments in the past three years. The important division of receptors into two major classes1 (1) adenosine (P1) receptors and (2) P2 purinoceptors, first suggested by Burnstock in 1978 (Ref.2), has been an abiding one that has set the stage for further subdivision of P2 purinoceptors into P2X and P2Y subtypes on the basis of pharmacological properties3. Later, Dubyak4 summarized the evidence that ATP worked through two different transduction mechanisms: intrinsic ion channels and G protein-coupled receptors. This information, coupled with the cloning of purinoceptors in 1993/94, led Abbracchio and Burnstock5 to propose that purinoceptors should be classified in two families: G protein-coupled receptors termed P2Y purinoceptors, and intrinsic ion channels termed P2X purinoceptors. Developments in recent years have borne out these expectations and a revised nomenclature, essentially adopting the Abbracchio and Burnstock proposal, can now be proposed.

[1]  G Burnstock,et al.  Is there a basis for distinguishing two types of P2-purinoceptor? , 1985, General pharmacology.

[2]  T. K. Harden,et al.  Second messenger cascade specificity and pharmacological selectivity of the human P2Y1‐purinoceptor , 1996, British journal of pharmacology.

[3]  G. Burnstock,et al.  An Introduction to Purinergic Receptors , 1981 .

[4]  M. Parmentier,et al.  Cloning, functional expression and tissue distribution of the human P2Y6 receptor. , 1996, Biochemical and biophysical research communications.

[5]  G Burnstock,et al.  Nomenclature and Classification of Purinoceptors* , 2005 .

[6]  M. Birch,et al.  Identification and cloning of human P2U purinoceptor present in osteoclastoma, bone, and osteoblasts , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[7]  E. Barnard,et al.  Identification of 6H1 as a P2Y purinoceptor: P2Y5. , 1996, Biochemical and biophysical research communications.

[8]  R. Boucher,et al.  Release, metabolism and interconversion of adenine and uridine nucleotides: implications for G protein-coupled P2 receptor agonist selectivity. , 1997, Trends in pharmacological sciences.

[9]  E. M. Jones,et al.  Cloning of rat and mouse P2Y purinoceptors. , 1995, Biochemical and biophysical research communications.

[10]  S. Hurt,et al.  [3H]2-phenylaminoadenosine ([3H]CV 1808) labels a novel adenosine receptor in rat brain. , 1992, The Journal of pharmacology and experimental therapeutics.

[11]  T. K. Harden,et al.  Expression of a cloned P2Y purinergic receptor that couples to phospholipase C. , 1994, Molecular pharmacology.

[12]  G. Housley,et al.  Identification of a short form of the P2xR1-purinoceptor subunit produced by alternative splicing in the pituitary and cochlea. , 1995, Biochemical and biophysical research communications.

[13]  L. Bolis,et al.  Cell membrane receptors for drugs and hormones : a multidisciplinary approach , 1978 .

[14]  Geoffrey Burnstock,et al.  A P2X purinoceptor cDNA conferring a novel pharmacological profile , 1995, FEBS letters.

[15]  G. Burnstock,et al.  Purinoceptors: are there families of P2X and P2Y purinoceptors? , 1994, Pharmacology & therapeutics.

[16]  E. Barnard,et al.  Molecular Cloning of a Novel P2 Purinoceptor from Human Erythroleukemia Cells* , 1996, The Journal of Biological Chemistry.

[17]  K. Shinozuka,et al.  Effects of alpha,beta-methylene ATP on the prejunctional purinoceptors of the sympathetic nerves of the rat caudal artery. , 1990, The Journal of pharmacology and experimental therapeutics.

[18]  G. Dubyak Signal transduction by P2-purinergic receptors for extracellular ATP. , 1991, American journal of respiratory cell and molecular biology.

[19]  G. Burnstock,et al.  Cloning and functional expression of a brain G‐protein‐coupled ATP receptor , 1993, FEBS letters.

[20]  S. Seino,et al.  Cloning and pharmacological characterization of a fourth P2X receptor subtype widely expressed in brain and peripheral tissues including various endocrine tissues. , 1996, Biochemical and biophysical research communications.

[21]  J. T. Turner,et al.  Cloning, Expression, and Chromosomal Localization of the Human Uridine Nucleotide Receptor Gene (*) , 1995, The Journal of Biological Chemistry.

[22]  G. Burnstock,et al.  A novel G protein-coupled P2 purinoceptor (P2Y3) activated preferentially by nucleoside diphosphates. , 1996, Molecular pharmacology.

[23]  R. North,et al.  A new class of ligand-gated ion channel defined by P2X receptor for extracellular ATP , 1994, Nature.

[24]  M. Parmentier,et al.  Cloning and Functional Expression of a Human Uridine Nucleotide Receptor (*) , 1995, The Journal of Biological Chemistry.

[25]  P. Séguéla,et al.  A novel neuronal P2x ATP receptor ion channel with widespread distribution in the brain , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[26]  B. Fredholm,et al.  Further characterization of the binding of the adenosine receptor agonist [3H]CGS 21680 to rat brain using autoradiography , 1995, Neuropharmacology.

[27]  G. Burnstock,et al.  A P2X purinoceptor expressed by a subset of sensory neurons , 1995, Nature.

[28]  G. M. Smith,et al.  Cloning and Characterization of a Bovine P2Y Receptor , 1995 .

[29]  R. North,et al.  An antagonist‐insensitive P2X receptor expressed in epithelia and brain. , 1996, The EMBO journal.

[30]  Stephen P. H. Alexander,et al.  TiPS Receptor and Ion Channel Nomenclature Supplement 1999 , 1999 .

[31]  R. North,et al.  Coexpression of P2X2 and P2X3 receptor subunits can account for ATP-gated currents in sensory neurons , 1995, Nature.

[32]  E. Kawashima,et al.  The Cytolytic P2Z Receptor for Extracellular ATP Identified as a P2X Receptor (P2X7) , 1996, Science.

[33]  G. Burnstock,et al.  Numbering of cloned P2 purinoceptors , 1996 .

[34]  E. Barnard,et al.  Cloning and chromosomal localization of the human P2Y1 purinoceptor. , 1996, Biochemical and biophysical research communications.

[35]  S. Antonarakis,et al.  Characterization and chromosomal localization of a human P2X receptor from the urinary bladder. , 1995, Receptors & channels.

[36]  Y. Takuwa,et al.  Molecular Cloning and Functional Analysis of a Novel P2 Nucleotide Receptor (*) , 1995, The Journal of Biological Chemistry.

[37]  D. Julius,et al.  New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor , 1994, Nature.

[38]  R. North,et al.  Cloning OF P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[39]  J. Linden,et al.  Comparison of A4 and A2a binding sites in striatum and COS cells transfected with adenosine A2a receptors. , 1995, The Journal of pharmacology and experimental therapeutics.

[40]  J. Boeynaems,et al.  Receptors responsive to extracellular pyrimidine nucleotides. , 1997, Trends in pharmacological sciences.